NO970210L - Heteroatomholdige cyklopentanopyridyl-oksazolidinoner - Google Patents

Heteroatomholdige cyklopentanopyridyl-oksazolidinoner

Info

Publication number
NO970210L
NO970210L NO970210A NO970210A NO970210L NO 970210 L NO970210 L NO 970210L NO 970210 A NO970210 A NO 970210A NO 970210 A NO970210 A NO 970210A NO 970210 L NO970210 L NO 970210L
Authority
NO
Norway
Prior art keywords
cyclopentanopyridyl
heteroatom
oxazolidinones
drug
oxazolidones
Prior art date
Application number
NO970210A
Other languages
English (en)
Norwegian (no)
Other versions
NO970210D0 (no
Inventor
Andreas Stolle
Dieter Haebich
Bernd Riedl
Martin Ruppelt
Stephan Bartel
Walter Guarnieri
Hanno Wild
Rainer Endermann
Hein-Peter Kroll
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO970210D0 publication Critical patent/NO970210D0/no
Publication of NO970210L publication Critical patent/NO970210L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO970210A 1996-01-18 1997-01-17 Heteroatomholdige cyklopentanopyridyl-oksazolidinoner NO970210L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19601627A DE19601627A1 (de) 1996-01-18 1996-01-18 Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone

Publications (2)

Publication Number Publication Date
NO970210D0 NO970210D0 (no) 1997-01-17
NO970210L true NO970210L (no) 1997-07-21

Family

ID=7783042

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970210A NO970210L (no) 1996-01-18 1997-01-17 Heteroatomholdige cyklopentanopyridyl-oksazolidinoner

Country Status (21)

Country Link
US (1) US5869659A (fr)
EP (1) EP0785201A1 (fr)
JP (1) JPH09202787A (fr)
KR (1) KR970059170A (fr)
AU (1) AU1012397A (fr)
BG (1) BG101139A (fr)
BR (1) BR9700716A (fr)
CA (1) CA2195177A1 (fr)
CZ (1) CZ15897A3 (fr)
DE (1) DE19601627A1 (fr)
EE (1) EE9700020A (fr)
HU (1) HU9700152D0 (fr)
IL (1) IL120016A0 (fr)
MA (1) MA24062A1 (fr)
NO (1) NO970210L (fr)
PL (1) PL317985A1 (fr)
SG (1) SG50001A1 (fr)
SK (1) SK6997A3 (fr)
TN (1) TNSN97010A1 (fr)
TR (1) TR199700039A2 (fr)
ZA (1) ZA97393B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9907183A (pt) 1998-01-23 2003-06-10 Versicor Inc Colet neas combinatórias de oxazolidinona, composições e processos de preparação
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
WO1999064417A2 (fr) 1998-06-05 1999-12-16 Astrazeneca Ab Composes chimiques
WO2001009107A1 (fr) 1999-07-28 2001-02-08 Pharmacia & Upjohn Company Oxazolidinones et leur utilisation comme anti-infectieux
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
AU2001272961A1 (en) 2000-06-30 2002-01-14 Pharmacia & Upjohn Company Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin
US6423844B1 (en) 2001-06-06 2002-07-23 The United States Of America As Represented By The Secretary Of The Navy Process for making 1,2,4-triazolo[4,3-a][1,3,5]triazine-3,5,7-triamine
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
DE60304360T2 (de) * 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
ATE344036T1 (de) * 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
CA2515269A1 (fr) * 2003-02-07 2004-08-19 Warner-Lambert Company Llc Derives d'oxazolidinone n-substitues par un noyau bicyclique, utilises comme agents antibacteriens
BRPI0407252A (pt) * 2003-02-07 2006-01-31 Warner Lambert Co Agentes antibacterianos.
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
WO2005082900A2 (fr) * 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Amidoxines d'oxazolidinone utilisees en tant qu'agents antibacteriens
EP1781642A1 (fr) * 2004-08-06 2007-05-09 Pharmacia & Upjohn Company LLC Oxazolidinones contenant des oxindoles en tant qu'agents antibacteriens
MX337906B (es) * 2006-10-19 2016-03-28 Signal Pharm Llc Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas.
US8110578B2 (en) 2008-10-27 2012-02-07 Signal Pharmaceuticals, Llc Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
SG10201500511TA (en) 2009-10-26 2015-03-30 Signal Pharm Llc Methods Of Synthesis And Purification Of Heteroaryl Compounds
PH12014500869A1 (en) 2011-10-19 2014-06-30 Signal Pharm Llc Treatment of cancer with tor kinase inhibitors
KR102040997B1 (ko) 2011-12-02 2019-11-27 시그날 파마소티칼 엘엘씨 7-(6-(2-히드록시프로판-2-일)피리딘-3-일)-1-((트랜스)-4-메톡시시클로헥실)-3,4-디히드로피라지노[2,3-b]피라진-2(1H)-온, 그의 고체 형태의 제약 조성물 및 그의 사용 방법
EP2817029B1 (fr) 2012-02-24 2019-07-10 Signal Pharmaceuticals, LLC Procédés de traitement du cancer du poumon non à petites cellules à l'aide d'une thérapie combinée d'inhibiteur de kinase
AU2013203714B2 (en) 2012-10-18 2015-12-03 Signal Pharmaceuticals, Llc Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity
PE20151995A1 (es) 2013-01-16 2016-01-13 Signal Pharm Llc Compuestos sustituidos de pirrolopirimidina, composiciones de los mismos, y metodos de tratamiento con los mismos
US9505764B2 (en) 2013-04-17 2016-11-29 Signal Pharmaceuticals, Llc Treatment of cancer with dihydropyrazino-pyrazines
US9630966B2 (en) 2013-04-17 2017-04-25 Signal Pharmaceuticals, Llc Treatment of cancer with dihydropyrazino-pyrazines
WO2014172436A1 (fr) 2013-04-17 2014-10-23 Signal Pharmaceuticals, Llc Polythérapie comprenant un inhibiteur de kinase tor et un composé de quinazolinone substitué en 5 pour le traitement du cancer
CA2908742C (fr) 2013-04-17 2021-06-01 Signal Pharmaceuticals, Llc Polytherapie comprenant un inhibiteur de la kinase tor et un analogue de la cytidine pour le traitement du cancer
CN105377299B (zh) 2013-04-17 2018-06-12 西格诺药品有限公司 用于治疗前列腺癌的包含二氢吡嗪并-吡嗪化合物和雄激素受体拮抗剂的组合疗法
CA2909579A1 (fr) 2013-04-17 2014-10-23 Signal Pharmaceuticals, Llc Therapie combinee comprenant un inhibiteur de la kinase tor et du n-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide pour le traitement d'un cancer
CA2909629C (fr) 2013-04-17 2022-12-13 Signal Pharmaceuticals, Llc Formulations pharmaceutiques, procedes, formes solides et methodes d'utilisation associes a la 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one
NZ629486A (en) 2013-05-29 2017-11-24 Signal Pharm Llc Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
US9512129B2 (en) 2014-04-16 2016-12-06 Signal Pharmaceuticals, Llc Solid forms comprising 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one and a coformer
WO2015160882A1 (fr) 2014-04-16 2015-10-22 Signal Pharmaceuticals, Llc Formes solides comprenant de la 7-(6- (2-hydroxypropan-2-yl) pyridin-3-yl)-1-(trans)-4-méthoxycyclohexyl)-3, 4-dihydropyrazino[2,3-b] pyrazin-2(1h)-one, et un co-formeur, leurs compositions et leurs procédés d'utilisation
NZ714742A (en) 2014-04-16 2017-04-28 Signal Pharm Llc Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
ES2823756T3 (es) 2014-04-16 2021-05-10 Signal Pharm Llc Métodos para tratar el cáncer usando terapia de combinación de inhibidores de quinasa TOR
WO2016010886A1 (fr) 2014-07-14 2016-01-21 Signal Pharmaceuticals, Llc Méthodes de traitement d'un cancer à l'aide de composés de pyrrolopyrimidine substitués, compositions de ceux-ci
NZ629796A (en) 2014-07-14 2015-12-24 Signal Pharm Llc Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use
TWI787284B (zh) 2017-06-22 2022-12-21 美商西建公司 以b型肝炎病毒感染表徵之肝細胞癌之治療

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4985429A (en) * 1987-10-09 1991-01-15 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4942183A (en) * 1987-10-16 1990-07-17 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
JP2865211B2 (ja) 1988-09-15 1999-03-08 ファルマシア・アンド・アップジョン・カンパニー ５’―インドリニル―５β―アミドメチルオキサゾリジン―２―オン類、３―（縮合環置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類および３―（窒素原子置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
JP2679745B2 (ja) * 1989-06-29 1997-11-19 明治製菓株式会社 アゾール誘導体及びそれらを有効成分とする抗潰瘍剤
JP2669579B2 (ja) 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
TW286317B (fr) 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone

Also Published As

Publication number Publication date
IL120016A0 (en) 1997-04-15
CA2195177A1 (fr) 1997-07-19
BG101139A (en) 1998-04-30
TR199700039A2 (tr) 1997-08-21
JPH09202787A (ja) 1997-08-05
AU1012397A (en) 1997-07-24
HU9700152D0 (en) 1997-03-28
PL317985A1 (en) 1997-07-21
BR9700716A (pt) 1998-10-06
TNSN97010A1 (fr) 2005-03-15
SG50001A1 (en) 1998-06-15
EP0785201A1 (fr) 1997-07-23
MA24062A1 (fr) 1997-10-01
ZA97393B (en) 1997-07-17
US5869659A (en) 1999-02-09
CZ15897A3 (en) 1997-08-13
MX9700388A (es) 1997-07-31
NO970210D0 (no) 1997-01-17
EE9700020A (et) 1997-08-15
SK6997A3 (en) 1997-09-10
DE19601627A1 (de) 1997-07-24
KR970059170A (ko) 1997-08-12

Similar Documents

Publication Publication Date Title
NO970210L (no) Heteroatomholdige cyklopentanopyridyl-oksazolidinoner
FI913624L (fi) Vispbar icke-mejeribaserad graedde, som baserar sig pao oelja i vaetskeform.
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
FI913215A0 (fi) Additionspolymeriseringskatalysator, som aktiveras medelst oxidering.
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
FI905958A7 (fi) Foerfarande foer framstaellning av substituerade cyklohexanoler, som verkar pao det centrala nervsystemet.
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
FI903726A0 (fi) Synkronisationsfoerfarande, som grundar sig pao korrelation.
FI903028A0 (fi) Polymerbaserade blandningskompositioner, som innehaoller destrukturerad staerkelse.
FI910131L (fi) Graedde, som inte baserar sig pao mejeriprodukten.
ITBO930030A1 (it) Involucro rigido, particolarmente per sigarette.
FI905020A0 (fi) Orala kompositioner, som innehaoller monoperoxisyror.
FI905957A7 (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
FI920076A0 (fi) Foerbaettrad tillslutningsmekanism foer verktyg, som anvaends foer att placera en foerslutning pao en bandfog.
MX9603516A (es) Derivados de oxima y su uso como pesticidas.
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
FI920080A0 (fi) Kulfaongare, som uppstannar kulor.
FI915623L (fi) 2b,19-etylenbryggsteroider som aromatasinhibitorer.
ID27733A (id) Metoksiminofenilasetamida
TR199501276A2 (tr) Sübstitüe edilmis sikloalkilamino-ve-alkoksi-heterosaykillar, üretilmelerine mahsus usul ve zararlilarla mücadele maddesi olarak kullanilmalari.
FI904090A0 (fi) Kopolymerater, vilka baserar sig pao omaettade radikalt ringoeppnande ketenderivat.
FI903237A0 (fi) Fenoxipyridinaminer och deras derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI902744A0 (fi) Genom bestraolning haordnande komposition, som baserar sig pao polyorganosiloxan som innehaoller en propanaldehydfunktion.
IL138117A0 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them